BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1513033)

  • 1. [Transfusion medicine in near future].
    Sekiguchi S
    Rinsho Byori; 1992 Jun; 40(6):617-25. PubMed ID: 1513033
    [No Abstract]   [Full Text] [Related]  

  • 2. [Present status and future of blood management in Japan].
    Sekiguchi S; Ikebuchi K
    Nihon Naika Gakkai Zasshi; 1996 Jun; 85(6):862-70. PubMed ID: 8753053
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood transfusion problems. Post-transfusional pathology. Proposal fo assessment].
    Utizi S; Barchiesi G; Albanesi A; Silvestri G; Silvestri G
    G Clin Med; 1989 Mar; 70(3):203-16. PubMed ID: 2668096
    [No Abstract]   [Full Text] [Related]  

  • 4. [Identification of leukocytic antigens and their significance of clinical transplantation and hematology. II. Antileukocytic antibodies as cause of fever after blood transfusion].
    Hronková-Zoulková J; Ivasková E
    Vnitr Lek; 1968 Jul; 14(7):662-6. PubMed ID: 5683096
    [No Abstract]   [Full Text] [Related]  

  • 5. Emerging viral infections relevant to transfusion medicine.
    Allain JP
    Blood Rev; 2000 Dec; 14(4):173-81. PubMed ID: 11124105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonhemolytic transfusion reactions: reducing the incidence with leukocyte-poor red blood cells.
    Lichtiger B; Osier LE
    South Med J; 1983 Mar; 76(3):419. PubMed ID: 6828921
    [No Abstract]   [Full Text] [Related]  

  • 7. Leukocyte-reduced blood components in transfusion medicine. Current indications and prospects for the future.
    Klapper EB; Goldfinger D
    Clin Lab Med; 1992 Dec; 12(4):711-21. PubMed ID: 1286560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region].
    Ouzan D; Pesle B; Baldini E; Rimbourg H; Darphin F; Cohen N; Brichetti A; Follana R
    Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood.
    Heuft HG; Berg T; Schreier E; Künkel U; Tacke M; Schwella N; Hopf U; Salama A; Huhn D
    Vox Sang; 1998; 74(3):161-7. PubMed ID: 9595643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the safety of transfusion therapy.
    Polesky HF
    Clin Lab Med; 1996 Dec; 16(4):975-88. PubMed ID: 8974206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood transfusion accidents].
    Salmon C
    Rev Prat; 1972 Mar; 22(9):1505-6 passim. PubMed ID: 4647338
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of leukocyte-reduced blood components.
    Miller JP; Mintz PD
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):69-90. PubMed ID: 7737945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of leukocyte poor blood: I. Effect on frequency and severity of non hemolytic transfusion reactions.
    Reverberi R; Moretti M; Ferrari L; Menini C
    Riv Emoter Immunoematol; 1983; 30(1):39-49. PubMed ID: 6635479
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of infectious disease transmission by blood and blood products.
    Aronson DL; Menaché D
    Prog Hematol; 1987; 15():221-41. PubMed ID: 3140296
    [No Abstract]   [Full Text] [Related]  

  • 15. Viruses.
    Barbara J
    Vox Sang; 2004 Jul; 87 Suppl1():95-7. PubMed ID: 15200615
    [No Abstract]   [Full Text] [Related]  

  • 16. [Transfusion medicine--Scandinavian recommendations].
    Jørgensen J; Jensson O; Eklund J; Kornstad L; Messeter L
    Nord Med; 1994; 109(2):61-3. PubMed ID: 8121792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDV infection from blood and blood products.
    Saracco G; Ponzetto A; Forzani B; Hele C; Rosina F; Lostia O; Caiola S; Rizzetto M
    Prog Clin Biol Res; 1987; 234():361-5. PubMed ID: 3628386
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention for hepatitis C virus transmission].
    Sekiguchi S
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):473-6. PubMed ID: 7687974
    [No Abstract]   [Full Text] [Related]  

  • 19. [Leukocyte antibodies and blood transfusion].
    Magallon M; Navarro JL; Martin-Villar J
    Sangre (Barc); 1970; 15(2):176-85. PubMed ID: 5431820
    [No Abstract]   [Full Text] [Related]  

  • 20. Informed consent, risk, and blood transfusion.
    Kolins J; Kolins MD
    J Thorac Cardiovasc Surg; 1990 Jul; 100(1):88-91. PubMed ID: 2366570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.